Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to: "Hypoxia-Induced Lineage Plasticity in Neuroblastoma: Advancing Signature Interpretation and Clinical Translation".

Clinical and translational science·2026
Same author

Maternal trans-vaccenic acid shapes neonatal T cell development and early-life immune imprinting.

Science (New York, N.Y.)·2026
Same author

Spatially resolved m<sup>6</sup>A profiling using m<sup>6</sup>A-ARTR-DBiT.

Nature methods·2026
Same author

CDS-localized m<sup>6</sup>A drives co-translational RNA decay to relieve biotic and abiotic endoplasmic reticulum stresses.

Nature plants·2026
Same author

Regulatory elements on chromatin-associated RNA 15 years beyond RNA epigenetics.

Nature chemical biology·2026
Same author

mRNA m<sup>6</sup>A modifications and the RNA-binding protein YTHDF1 affect translational control in both normal and pathological learning.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Video

Updated: Sep 19, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

713

YTHDFs as radiotherapy checkpoints in tumor immunity.

Chuangyu Wen1,2, Emile Z Naccasha1,2, Chuan He3,4

  • 1Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.

The Journal of Experimental Medicine
|June 5, 2025
PubMed
Summary

YTHDF proteins regulate DNA repair and immune responses to radiotherapy (RT). Targeting these N6-methyladenosine (m6A) readers may enhance RT efficacy and improve cancer treatment outcomes.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.9K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.1K

Related Experiment Videos

Last Updated: Sep 19, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

713
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.9K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.1K

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Radiotherapy (RT) is a key cancer treatment that damages tumor DNA and influences the tumor immune microenvironment (TIME).
  • Tumor-intrinsic DNA repair and immune-suppressive mechanisms can limit RT efficacy.
  • YTHDF proteins, which read N6-methyladenosine (m6A) modifications, are critical in cancer progression and immune regulation.

Purpose of the Study:

  • To review the dual roles of YTHDF proteins in tumor cells and the TIME concerning RT.
  • To explore how YTHDF proteins influence DNA damage repair and immune responses to RT.
  • To discuss YTHDF-targeting strategies for enhancing RT and immunotherapy.

Main Methods:

  • Literature review of studies on YTHDF proteins, radiotherapy, DNA repair, and the tumor immune microenvironment.
  • Analysis of the regulatory functions of YTHDF proteins in cancer cells and immune cells.
  • Synthesis of current research on YTHDF inhibitors and their combination with RT and immunotherapy.

Main Results:

  • YTHDF proteins play complex roles in both promoting and suppressing antitumor responses to RT.
  • These proteins impact DNA damage repair pathways within tumor cells.
  • YTHDF proteins significantly modulate the immune cell composition and function within the TIME.

Conclusions:

  • YTHDF proteins are critical regulators of tumor response to radiotherapy.
  • Targeting YTHDF proteins offers a promising strategy to overcome RT resistance.
  • Combination therapies involving YTHDF inhibitors, RT, and immunotherapy hold potential for improved cancer treatment.